Literature DB >> 33176118

Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis.

Yun Chen1, Michael R Strickland2, Andrea Soranno3, David M Holtzman4.   

Abstract

Apolipoprotein E (ApoE) is of great interest due to its role as a cholesterol/lipid transporter in the central nervous system (CNS) and as the most influential genetic risk factor for Alzheimer disease (AD). Work over the last four decades has given us important insights into the structure of ApoE and how this might impact the neuropathology and pathogenesis of AD. In this review, we highlight the history and progress in the structural and molecular understanding of ApoE and discuss how these studies on ApoE have illuminated the physiology of ApoE, receptor binding, and interaction with amyloid-β (Aβ). We also identify future areas of study needed to advance our understanding of how ApoE influences neurodegeneration.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AD; Alzheimer disease; Amyloid-β; ApoE; Apolipoprotein E; Aβ; LDLR; low-density lipoprotein receptor

Mesh:

Substances:

Year:  2020        PMID: 33176118      PMCID: PMC7931158          DOI: 10.1016/j.neuron.2020.10.008

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  155 in total

1.  Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer.

Authors:  Qin Xu; Walter J Brecht; Karl H Weisgraber; Robert W Mahley; Yadong Huang
Journal:  J Biol Chem       Date:  2004-03-30       Impact factor: 5.157

2.  Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors.

Authors:  R W Mahley; K H Weisgraber; T L Innerarity
Journal:  Biochim Biophys Acta       Date:  1979-10-26

3.  Rapid endocytosis of the low density lipoprotein receptor-related protein modulates cell surface distribution and processing of the beta-amyloid precursor protein.

Authors:  Judy A Cam; Celina V Zerbinatti; Yonghe Li; Guojun Bu
Journal:  J Biol Chem       Date:  2005-02-10       Impact factor: 5.157

4.  Binding of apolipoprotein E inhibits the oligomer growth of amyloid-β peptide in solution as determined by fluorescence cross-correlation spectroscopy.

Authors:  Sonny Ly; Robin Altman; Jitka Petrlova; Yu Lin; Silvia Hilt; Thomas Huser; Ted A Laurence; John C Voss
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

Review 5.  The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution.

Authors:  W H Li; M Tanimura; C C Luo; S Datta; L Chan
Journal:  J Lipid Res       Date:  1988-03       Impact factor: 5.922

6.  Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.

Authors:  Chia-Chen Liu; Jin Hu; Na Zhao; Jian Wang; Na Wang; John R Cirrito; Takahisa Kanekiyo; David M Holtzman; Guojun Bu
Journal:  J Neurosci       Date:  2017-03-08       Impact factor: 6.167

7.  Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.

Authors:  T Wisniewski; A Golabek; E Matsubara; J Ghiso; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

8.  Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.

Authors:  D A Sanan; K H Weisgraber; S J Russell; R W Mahley; D Huang; A Saunders; D Schmechel; T Wisniewski; B Frangione; A D Roses
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

9.  Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid.

Authors:  M J LaDu; T M Pederson; D E Frail; C A Reardon; G S Getz; M T Falduto
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

10.  Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.

Authors:  Tadafumi Hashimoto; Alberto Serrano-Pozo; Yukiko Hori; Kenneth W Adams; Shuko Takeda; Adrian Olaf Banerji; Akinori Mitani; Daniel Joyner; Diana H Thyssen; Brian J Bacskai; Matthew P Frosch; Tara L Spires-Jones; Mary Beth Finn; David M Holtzman; Bradley T Hyman
Journal:  J Neurosci       Date:  2012-10-24       Impact factor: 6.167

View more
  35 in total

Review 1.  Interpretable artificial intelligence and exascale molecular dynamics simulations to reveal kinetics: Applications to Alzheimer's disease.

Authors:  William Martin; Gloria Sheynkman; Felice C Lightstone; Ruth Nussinov; Feixiong Cheng
Journal:  Curr Opin Struct Biol       Date:  2021-10-07       Impact factor: 6.809

Review 2.  APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

Authors:  Rosalía Fernández-Calle; Sabine C Konings; Javier Frontiñán-Rubio; Juan García-Revilla; Lluís Camprubí-Ferrer; Martina Svensson; Isak Martinson; Antonio Boza-Serrano; José Luís Venero; Henrietta M Nielsen; Gunnar K Gouras; Tomas Deierborg
Journal:  Mol Neurodegener       Date:  2022-09-24       Impact factor: 18.879

3.  The Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review.

Authors:  Lianne A Hulshof; Danny van Nuijs; Elly M Hol; Jinte Middeldorp
Journal:  Front Cell Neurosci       Date:  2022-06-16       Impact factor: 6.147

Review 4.  ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias.

Authors:  Yuka A Martens; Na Zhao; Chia-Chen Liu; Takahisa Kanekiyo; Austin J Yang; Alison M Goate; David M Holtzman; Guojun Bu
Journal:  Neuron       Date:  2022-03-16       Impact factor: 18.688

Review 5.  APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease.

Authors:  Samira Parhizkar; David M Holtzman
Journal:  Semin Immunol       Date:  2022-02-26       Impact factor: 10.671

6.  Astrogliosis and episodic memory in late life: higher GFAP is related to worse memory and white matter microstructure in healthy aging and Alzheimer's disease.

Authors:  Brianne M Bettcher; Kaitlin E Olson; Nichole E Carlson; Brice V McConnell; Tim Boyd; Vanesa Adame; D Adriana Solano; Paige Anton; Neil Markham; Ashesh A Thaker; Alexandria M Jensen; Erika N Dallmann; Huntington Potter; Christina Coughlan
Journal:  Neurobiol Aging       Date:  2021-02-26       Impact factor: 5.133

Review 7.  Cholesterol and Alzheimer's Disease; From Risk Genes to Pathological Effects.

Authors:  Femke M Feringa; Rik van der Kant
Journal:  Front Aging Neurosci       Date:  2021-06-24       Impact factor: 5.750

8.  The Association Between Plasma α-Synuclein (α-syn) Protein, Urinary Alzheimer-Associated Neuronal Thread Protein (AD7c-NTP), and Apolipoprotein Epsilon 4 (ApoE ε4) Alleles and Cognitive Decline in 60 Patients with Alzheimer's Disease Compared with 28 Age-Matched Normal Individuals.

Authors:  Shuang Lv; Xiao Zhou; Yiming Li; Shujuan Zhang; Yu Wang; Shuhong Jia; Xiaoqian Niu; Lei Wang; Dantao Peng
Journal:  Med Sci Monit       Date:  2021-07-27

9.  ApoE and immunity in Alzheimer's disease and related tauopathies: Low-density lipoprotein receptor to the rescue.

Authors:  Andrew S Mendiola; Reshmi Tognatta; Zhaoqi Yan; Katerina Akassoglou
Journal:  Neuron       Date:  2021-08-04       Impact factor: 18.688

10.  Autocrine Effects of Brain Endothelial Cell-Produced Human Apolipoprotein E on Metabolism and Inflammation in vitro.

Authors:  Felecia M Marottoli; Troy N Trevino; Xue Geng; Zarema Arbieva; Pinal Kanabar; Mark Maienschein-Cline; James C Lee; Sarah E Lutz; Leon M Tai
Journal:  Front Cell Dev Biol       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.